Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block
Effect of Intravenous Dexmedetomidine on the Analgesic Duration of Infraclavicular Block With Ropivacaine for Upper Limb Surgery: a Prospective, Randomized, Double Blind Study
The study will evaluate the effect of Dexmedetomidine sedation on the duration of infraclavicular block in patients scheduled for surgery of elbow, forearm and/or hand. All patients will receive infraclavicular block before the surgery and then they will be randomized to receive either Dexmedetomidine or Propofol sedation. Duration of the sensory block will be evaluated in recovery room, 24 and 48 hours after the surgery.
Hypothesis:
Primary: Dexmedetomidine sedation increases the duration of sensory infraclavicular block in patients scheduled for upper limb surgery.
Secondary: Dexmedetomidine sedation
- Gives an adequate level of sedation during the surgical procedure
- Reduces the requirements of postoperative opioids
- Improves the quality of sleep on the night of the surgery
- Increases patients satisfaction regarding the anesthesia technique
- Dexmedetomidine sedation is safe and easy to use
- Dexmedetomidine sedation provides less respiratory depression during the procedure.
調査の概要
詳細な説明
Methodology:
Study design A randomized, prospective, double blind study.
Patient groups Group 1 (control group) This group will have infraclavicular block and sedation during surgery with intravenous Propofol.
Group 2 (intervention group) This group will have infraclavicular block and sedation with intravenous Dexmedetomidine.
Recruitment and Informed consent: Recruitment will take place in the preoperative clinic or surgical day care unit.
Duration of study: We estimate that 3 patients per week will be eligible and agree to participate. One year should therefore provide adequate time for study completion.
Data analysis:
Descriptive statistics will be used to present baseline characteristics for the two groups.
T-test or Mann-Whitney U- test will be used to compare these baseline values between the two groups. Quantitative data like pain scores and narcotic consumption will be compared using repeated measures ANOVA within the groups and two tailed unpaired t-test between groups (or Mann- Whitney-U test if skewed distribution). The nonparametric data will be analyzed using Chi squared test. P less than 0.05 will be considered statistically significant. Continuous variables will be assessed for normality and will be presented as mean (SD) or median with interquartile range (IQR) as appropriate. Categorical variables will be assessed using frequency tables and Fisher's exact test. The interval between the onset of the sensory block and first analgesic request will be analyzed by Kaplan-Meier survival analysis.
Protocol: The study will be performed on patients undergoing ambulatory hand, forearm or elbow surgery. After informed consent, the patients will be randomized to a study group using a computer generated random number table and sealed envelope technique. Following this the patients will be taken to the block room for performing the infraclavicular block, using standard monitors that will include non-invasive blood pressure, electrocardiogram and pulse oximetry.
All patients will receive ultrasound guided infraclavicular block with the standard protocol of the Block Room in St. Joseph Hospital. After the block, the patient will be moved to the operating room for the surgery where sedation with Dexmedetomidine or Propofol will be started as per the randomization. In order to blind the patient, the syringe and tubing will be covered with towels. The patients will be allocated to one of the two groups:
Group 1: Patients will receive intravenous Dexmedetomidine sedation bolus 0.5mcg/kg in 10 minutes and then 0.2-0.5 mg/kg/hr infusion. The infusion will be stopped 15 minutes before the end of surgery.
Group 2: Patients will receive intravenous Propofol sedation 50-100 mcg/kg/min infusion. The infusion will be stopped 15 minutes before the end of surgery.
Sedation score and hemodynamic profile during the surgery will be recorded every 15 minutes. Oxygen will be provided through facial mask. Total dose of narcotic used will be recorded.
After the surgical procedure, patients will be moved to the Post Anesthetic Care Unit (PACU), where an independent blinded observer not involved in the performance of the block or intraoperative care of the patient, will follow up the patients in the postoperative period.
The patients will be assessed for the site and severity of pain at rest at the arrival in the PACU. Pain score will be the Numerical Rating Score (NRS) on a scale of 0 to 10 where 0 is no pain and 10 the worst pain ever experienced. Data regarding duration of surgery and the duration of stay in PACU will also be collected from the nursing records. Opioids requirement in PACU will also be collected from these records. Complications, if any will be noted.
The patients will be assessed for pain at the surgical site at the time of discharge from PACU. They will also be given a diary to take home. Patient will be educated regarding the NRS and asked to record in the diary after discharge from the PACU until 20:00 hours. They will also be asked to record when they require first analgesic dose, the time of return of sensation in dorsal area of the hand/finger and also the time when they are able to extend the wrist.
Patients will be instructed to take their oral rescue analgesic once the pain is score >5/10.
Patients will be contacted by phone 24 hours and 48 hours after their time of arrival in PACU (time 0). They will be reminded regarding entry in the diary. They will also be asked about quality of sleep.
Patient satisfaction will be documented at 24 and 48 hours on a visual analogue scale where 0 is totally dissatisfied and 100 is totally satisfied.
The total participation time for the patients is for 2 days.
Sample size estimation The sample size is calculated for the primary outcome measure, which is the duration of the sensory block.
The duration of sensory infraclavicular block when the local anesthetic is Ropivacaine is 402 (± 183) minutes (Abdallah et al. Anesthesiology 2016; 124:683-95). With an equivalence limit (d) of 180 minutes and the calculation of the sample size with the following formula:
n = f(α, β) × 2 × σ2 / d2 (non-inferiority) and n = f(α/2, β) × 2 × σ2 / (μ1 - μ2)2 (superiority) This showed 27 patients per group (non-inferiority) and 32 patients per group (superiority), were required to ensure adequate sample size with an α of 2.5% and 95% power. We plan to have 50 patients per group, considering a high non-compliance rate.
Randomization: This will be performed using a computer generated randomization and closed envelope system. Patients will be randomized on the day of the surgical procedure. This study will be double blind because patients, anesthesiologist performing the infraclavicular block and the evaluator in the postoperative setting will not know the allocation group. The anesthesiologist providing the sedation in the Operating Room will prepare the sedative agents (Propofol and/or Dexmedetomidine) and will cover the infusions with drapes (Propofol is a white solution, the only way to hide it is to cover it with drapes). This person will not be blinded but will also not be part of the study.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Ontario
-
London、Ontario、カナダ、N6A 4V2
- Saint Joseph's Health Care London
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Male and females of 16-80 years of age, scheduled for hand, forearm and elbow ambulatory surgery with an infraclavicular block.
- American Society of Anesthesiologist (ASA) Class I, II, III
- Ability to cooperate with study related procedures
Exclusion Criteria:
- ASA IV
- Narcotic dependent (opioid intake more than 3 months) or chronic pain conditions
- Associated significant cardiac or respiratory disease, neurological deficits
- Coexisting hematological disorder or with deranged coagulation
- Pre-existing major organ dysfunction
- Psychiatric illnesses
- Emergency surgery
- Lack of informed consent
- Allergy to any of the drugs used in the study
- Surgical procedure duration greater than 3 hours
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
アクティブコンパレータ:Propofol sedation.
This group will have infraclavicular block and sedation during surgery with intravenous Propofol.
Patients will receive intravenous Propofol sedation 50-100 mcg/kg/min infusion.
The infusion will be stopped 15 minutes before the end of surgery.
|
Intravenous sedation with propofol
All patients will receive ultrasound guided infraclavicular block with the standard protocol of the Block Room in St.
Joseph Hospital.
|
実験的:Dexmedetomidine sedation.
This group will have infraclavicular block and sedation with intravenous Dexmedetomidine.
Patients will receive intravenous Dexmedetomidine sedation bolus 0.5mcg/kg in 10 minutes and then 0.2-0.5 mg/kg/hr infusion.
The infusion will be stopped 15 minutes before the end of surgery.
|
All patients will receive ultrasound guided infraclavicular block with the standard protocol of the Block Room in St.
Joseph Hospital.
Intravenous sedation with dexmedetomidine
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
The duration of sensory infraclavicular block in patients scheduled for upper limb surgery.
時間枠:The primary outcome will be the duration of the sensory infraclavicular block in minutes, from the moment that the block is perfomed and the moment of first analgesic request.
|
In the data collection form will be record the time of performance of the infraclavicular block.
The patients will have a diary where they will record the time of the day when day have the first analgesic request because of pain in the surgical site.
|
The primary outcome will be the duration of the sensory infraclavicular block in minutes, from the moment that the block is perfomed and the moment of first analgesic request.
|
協力者と研究者
捜査官
- 主任研究者:Shalini Dhir, MD, FRCPC、Lawson Health Research Institute & Western University
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
術後の痛みの臨床試験
-
Dexa Medica Group完了